Its CEO Scott Brunner issued the following statement on LinkedIn: In a statement today accompanying a new tranche of warning letters sent to telehealth platforms, FDA Commissioner Marty Makary is quoted as saying: Compounded drugs can be important for overcoming shortages or meeting unique patient needs but compounders should not try to circumvent FDAs approval process by mass-marketing compounded drugs. Im puzzled by the phrasing
Additionally, blood thinning medicines like warfarin may change how it works and require careful monitoring of blood clotting times by your doctor
Building flexibility into your subscription tiers offering a light or mini meal kit plan with smaller components and fewer calories is a GLP-1 food brand strategy that directly protects meal kit subscription retention among this fast-growing demographic
Topical Peptides: Comparing Side Effects When administering peptides, the choice between injectable and topical forms can significantly impact results and safety
Because higher doses of GLP-1s commonly cause nausea, bloating, or digestive discomfort, microdosing may make the therapy more tolerable without sacrificing potential benefits